Grace Kim is a skilled scientist with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Scientist in Research Inflammation at Gilead Sciences since December 2024, Grace previously held multiple roles at Verge Genomics, including Associate Principal Scientist in Translational Medicine and Scientist in Drug Discovery, from January 2020 to December 2024. Prior to that, Grace spent nearly a decade at Nektar Therapeutics in various capacities, achieving progression from Research Associate II to Senior Research Associate and Associate Scientist from June 2010 to January 2020. Grace's earlier career includes research positions at XenoPort, FibroGen, Renovis, and the University of California Santa Cruz, culminating in a B.S. in Molecular, Cell, and Developmental Biology from the same institution.
This person is not in the org chart
This person is not in any teams
This person is not in any offices